CD8A and cancer: By inhibiting a broad range of glutamine‐dependent enzymes, including GLS and amidotransferases, they suppress oxidative and glycolytic metabolism in cancer cells, ultimately reducing hypoxia, acidosis, and nutrient depletion, creating a more favorable environment for CD8+ T‐cell function.